• Matuzumab
    Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR)...
    8 KB (842 words) - 19:53, 20 December 2023
  • Thumbnail for Testosterone
    Testosterone
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    149 KB (15,717 words) - 11:43, 7 August 2024
  • List of drugs: M–Md
    (INN) masoprocol (INN) Masterone (Syntex) Matulane (Sigma Tau Pharms) matuzumab (INN) mavacoxib (USAN) Mavik mavorixafor (INN) mavrilimumab (INN) Maxair...
    4 KB (272 words) - 02:01, 1 July 2024
  • Thumbnail for Dexamethasone
    Dexamethasone
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    68 KB (5,999 words) - 09:02, 6 August 2024
  • Thumbnail for Amitriptyline
    Amitriptyline
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    93 KB (8,776 words) - 07:12, 1 August 2024
  • Thumbnail for Erythropoietin
    Erythropoietin
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    31 KB (3,428 words) - 11:40, 29 July 2024
  • Thumbnail for Insulin
    Insulin
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    121 KB (13,799 words) - 03:46, 30 July 2024
  • Cerebrolysin
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    13 KB (1,177 words) - 16:45, 16 July 2024
  • Thumbnail for Trastuzumab deruxtecan
    Trastuzumab deruxtecan
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    25 KB (2,086 words) - 02:24, 16 July 2024
  • Thumbnail for Fruquintinib
    Fruquintinib
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    10 KB (579 words) - 06:46, 26 June 2024
  • Anti-VEGF
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    14 KB (1,671 words) - 12:47, 23 April 2024
  • Thumbnail for Osimertinib
    Osimertinib
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    17 KB (1,489 words) - 05:47, 7 April 2024
  • Thumbnail for HER2
    HER2
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    43 KB (4,651 words) - 13:41, 27 July 2024
  • Neurotrophic factors
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    16 KB (1,784 words) - 04:08, 6 January 2024
  • IGF-1 LR3
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    5 KB (412 words) - 23:17, 19 June 2023
  • Bevacizumab
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    73 KB (6,429 words) - 05:45, 5 August 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    List of therapeutic monoclonal antibodies
    receptor Mavrilimumab mab human GMCSF receptor α-chain rheumatoid arthritis Matuzumab mab humanized Epidermal growth factor receptor (EGFR) colorectal, lung...
    135 KB (4,054 words) - 22:35, 2 July 2024
  • Thumbnail for Insulin-like growth factor 1
    Insulin-like growth factor 1
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    35 KB (4,573 words) - 03:04, 5 August 2024
  • Amivantamab
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    23 KB (1,757 words) - 06:04, 16 July 2024
  • Thumbnail for Faricimab
    Faricimab
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    20 KB (1,543 words) - 06:38, 10 March 2024
  • Thumbnail for Nintedanib
    Nintedanib
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    34 KB (3,021 words) - 12:39, 5 August 2024
  • Thumbnail for Dihexa
    Dihexa
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    6 KB (460 words) - 19:16, 8 July 2024
  • Thumbnail for Tyrosine kinase inhibitor
    Tyrosine kinase inhibitor
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    10 KB (1,179 words) - 18:31, 8 August 2024
  • Thumbnail for Nerve growth factor
    Nerve growth factor
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    24 KB (2,872 words) - 06:27, 22 July 2024
  • Thumbnail for Platelet-derived growth factor
    Platelet-derived growth factor
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    24 KB (2,877 words) - 10:08, 2 June 2024
  • Thumbnail for Filgrastim
    Filgrastim
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    24 KB (1,700 words) - 04:21, 2 July 2024
  • Thumbnail for Imatinib
    Imatinib
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    71 KB (6,702 words) - 05:32, 9 August 2024
  • Thumbnail for Brain-derived neurotrophic factor
    Brain-derived neurotrophic factor
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    46 KB (5,344 words) - 04:27, 29 July 2024
  • Wnt signaling pathway
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    64 KB (7,427 words) - 21:08, 3 August 2024
  • Thumbnail for Tyrosine kinase
    Tyrosine kinase
    Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
    43 KB (5,251 words) - 10:44, 24 June 2024